| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biochemistry and Molecular Biology I, Faculty of Chemistry, and the Department of Biochemistry and Molecular Biology III, Faculty of Medicine (E.B.), Universidad Complutense, 28040 Madrid, Spain
Address all correspondence and requests for reprints to: Dr. Maria A. Bosch, Department of Biochemistry and Molecular Biology, Faculty of Chemistry, Universidad Complutense, 28040 Madrid, Spain.
Glucagon-like peptide-1 (GLP-1) receptor messenger RNA has been identified in cells considered type II pneumocytes that are involved in the synthesis and secretion of the pulmonary surfactant. In an attempt to open new insights into the control of surfactant secretion, we studied the effects of glucagon-related peptides in this process. Accordingly, type II pneumocytes were isolated from Wistar rat lungs and cultured overnight with [methyl-14C]choline, and then the basal and stimulated secretions of [14C]phosphatidylcholine were measured. GLP-1(7–36)amide stimulated phosphatidylcholine secretion in a concentration-dependent manner in the 1–100 nM range; the concentration of the peptide that produced a half-maximal response was 10 nM. Exendin-4 induced similar effects. No changes were observed when GLP-1-(1–37), GLP-2, or exendin-(9–39) was added to the medium. However, the latter reversed the stimulatory effects of GLP-1-(7–36)amide and exendin-4. A study of the mechanism through which GLP-1-(7–36)amide exerts its stimulatory effect was carried out using different agents that are well known stimulants of phosphatidylcholine secretion. GLP-1-(7–36)amide did not produce any change in the stimulatory effect observed with terbutaline or 8-bromo-cAMP, suggesting the involvement of a cAMP-dependent protein kinase in the stimulatory effect of this peptide on phosphatidylcholine secretion. It was further supported by the use of inhibitors of protein kinases and by the stimulation of cAMP production in type II pneumocytes incubated with either GLP-1-(7–36)amide or exendin-4.
This article has been cited by other articles:
 |
|
 |
|
  A. V. Andreeva, M. A. Kutuzov, and T. A. Voyno-Yasenetskaya Regulation of surfactant secretion in alveolar type II cells Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L259 - L271. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez The cytoplasmic domain close to the transmembrane region of the glucagon-like peptide-1 receptor contains sequence elements that regulate agonist-dependent internalisation J. Endocrinol., July 1, 2005; 186(1): 221 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Vazquez, I. Roncero, E. Blazquez, and E. Alvarez Substitution of the cysteine 438 residue in the cytoplasmic tail of the glucagon-like peptide-1 receptor alters signal transduction activity J. Endocrinol., April 1, 2005; 185(1): 35 - 44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. VARA, J. ARIAS-DÍAZ, C. GARCIA, J. L. BALIBREA, and E. BLÁZQUEZ Glucagon-like Peptide-1(7-36) Amide Stimulates Surfactant Secretion in Human Type II Pneumocytes Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 840 - 846. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. P. Mommsen Glucagon-like Peptide-1 in Fishes: The Liver and Beyond Integr. Comp. Biol., April 1, 2000; 40(2): 259 - 268. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Kieffer and J. Francis Habener The Glucagon-Like Peptides Endocr. Rev., December 1, 1999; 20(6): 876 - 913. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. M. Barragan, J. Eng, R. Rodriguez, and E. Blazquez Neural contribution to the effect of glucagon-like peptide-1-(7---36) amide on arterial blood pressure in rats Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E784 - E791. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
